London based startup Cryogenx, whose portable body cooling device offers a rapid response for heat-related illness, has secured a £150,000 investment from British Design Fund, as part of a wider £800,000 raise that included existing shareholders, angel investors and a US-based fund.

Nanomaterial producer iGii has raised £8.8 million of new funding to accelerate growth. The Stirling-based company, formerly known as Integrated Graphene, will use the funds to accelerate customer projects, increase its manufacturing capacity, and deepen its research and development to explore further applications of its patented Gii^TM material. iGii plans to expand its facilities and continue creating highly skilled local jobs.

Floreon Technology, a cutting-edge bioplastics firm which was spun out of a successful partnership with the University of Sheffield is set to receive a £250,000 investment from CPI Enterprises.

OGI Bio, a leading Scottish biotechnology company, has secured follow-on funding of £650,000 in a deal led by TRICAPITAL Angels and supported by Scottish Enterprise, Merleview, Apollo, and Old College Capital to accelerate the company's growth and expansion in the UK, EU, and US biotechnology sectors.

Evoralis Ltd is one of the first company to benefit from the programme and its investment portfolio will be managed by CPI Enterprises, the investment arm of CPI.

The Royal College of Art's RCA Design & Innovation S/EIS Fund has invested in Revive Innovations +, a med-tech business developing a new compact class of auto injectors.

USA: S2N Health, Inc. has successfully secured seed funding to fuel the growth of the company’s RepSignal^TM medtech customer intelligence SaaS platform, and to develop a robust roadmap of AI-powered solutions for accelerating the market impact of healthcare technologies. The round was led by Excelerate Health Ventures, a premier digital health fund focused on healthcare software and technology-enabled services, with participation from other established healthcare and technology investors, including Boston Millennia Partners and Robin Hood Ventures. 

FRANCE: En Carta Diagnostics, a deeptech start-up developing rapid Point-of-Care (POC) molecular diagnostics kits, has announced €1.5M ($1.63M) in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a prototype diagnostic kit for its flagship indication, the debilitating Lyme disease, while ensuring its ability to scale industrially. 

The startup led by the Raiola brothers and supported by IAG and Italians in VC Partners is revolutionizing healthcare access with an AI platform for musculoskeletal services. 

Lola Cares, a pioneering health tech company, has announced the successful closure of its first funding round, raising £250,000 from SFC Capital. A significant step towards the emerging company’s mission to enhance the care experience in an overstretched social care sector. The funding is set to enhance Lola’s conversational AI capabilities and broaden its impact in the care sector. 

Angel Academe has made its 50th investment in PreActiv, an innovative platform that optimises patients before surgery, using technology to create individualised prehabilitation programmes. 

Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital. Series A financing to advance clinical development of lead candidate RLS-1496 into Phase 1 studies this year in chronic atopic dermatitis and chronic psoriasis. Financing will also advance respiratory program, recipient of a substantial CIRM grant last year, to development candidate nomination for idiopathic pulmonary fibrosis.